Crossmark

HuR inhibition overcomes cFLIP-mediated doxorubicin resistance in triple-negative breast cancer

Published Online: 2024-12-20

Authors

Wei, Lanjing https://orcid.org/0000-0001-9170-0931
Kim, Sung Hae

Armaly, Ahlam M.

Aubé, Jeffrey

Xu, Liang

Wu, Xiaoqing https://orcid.org/0000-0003-2076-4107
License Information

Text and Data Mining valid from 2024-12-20

Version of Record valid from 2024-12-20
More Information

Article History

Received: 12 May 2024

Accepted: 10 December 2024

First Online: 20 December 2024

Competing interests

: The authors declare no competing interests.

Document is current